KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Taxes: 2020-2024

Historic Change in Taxes for AbCellera Biologics (ABCL) over the last 5 years, with Dec 2024 value amounting to $6.7 million.

  • AbCellera Biologics' Change in Taxes fell 342.82% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year increase of 36.05%. This contributed to the annual value of $6.7 million for FY2024, which is 78.17% down from last year.
  • Latest data reveals that AbCellera Biologics reported Change in Taxes of $6.7 million as of FY2024, which was down 78.17% from $30.5 million recorded in FY2023.
  • Over the past 5 years, AbCellera Biologics' Change in Taxes peaked at $36.4 million during FY2020, and registered a low of -$88.6 million during FY2022.
  • Moreover, its 3-year median value for Change in Taxes was $6.7 million (2024), whereas its average is -$17.2 million.
  • In the last 5 years, AbCellera Biologics' Change in Taxes slumped by 554.91% in 2022 and then surged by 134.38% in 2023.
  • Yearly analysis of 5 years shows AbCellera Biologics' Change in Taxes stood at $36.4 million in 2020, then plummeted by 137.16% to -$13.5 million in 2021, then tumbled by 554.91% to -$88.6 million in 2022, then spiked by 134.38% to $30.5 million in 2023, then tumbled by 78.17% to $6.7 million in 2024.